← Back to directory

Alberto Martini

Researcher Next ID · RN-034968

Researcher · Biochemistry, Genetics and Molecular Biology

Agenzia Regionale Prevenzione e Ambiente della Regione Emilia-Romagna

Modena, Italy

Accepting doctoral researchersFunding unknown
Works count
1,048
Citation count
48,890
H-index
111
i10-index
448

Research interests

Biochemistry, Genetics and Molecular Biology
Health Professions
Medicine
Autoimmune and Inflammatory Disorders Research
Adolescent and Pediatric Healthcare
Rheumatoid Arthritis Research and Therapies
Inflammasome and immune disorders
Systemic Lupus Erythematosus Research

Publications

  • Classification criteria for autoinflammatory recurrent fevers

    Annals of the Rheumatic Diseases · 2019 · https://doi.org/10.1136/annrheumdis-2019-215048

  • Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus

    The Journal of Rheumatology · 2018 · 10.3899/jrheum.180168

  • Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence

    JAMA · 2016 · https://doi.org/10.1001/jama.2016.15826

  • 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis

    Annals of the Rheumatic Diseases · 2016 · 10.1136/annrheumdis-2015-208982

  • 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative

    Arthritis & Rheumatology · 2015 · 10.1002/art.39332

  • Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients

    Arthritis & Rheumatology · 2014 · 10.1002/art.38802

  • The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry

    Annals of the Rheumatic Diseases · 2013 · 10.1136/annrheumdis-2013-204184

  • Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis

    New England Journal of Medicine · 2012 · 10.1056/nejmoa1205099

  • Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis

    New England Journal of Medicine · 2012 · 10.1056/nejmoa1112802

  • Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis

    Annals of the Rheumatic Diseases · 2012 · https://doi.org/10.1136/annrheumdis-2012-201940

  • Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review

    Annals of the Rheumatic Diseases · 2012 · 10.1136/annrheumdis-2011-201268

  • Juvenile idiopathic arthritis

    The Lancet · 2011 · 10.1016/s0140-6736(11)60244-4

  • 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features

    Arthritis Care & Research · 2011 · 10.1002/acr.20460

  • EULAR/PRINTO/PRES criteria for Henoch–Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria

    Annals of the Rheumatic Diseases · 2010 · https://doi.org/10.1136/ard.2009.116657

  • Development and validation of a composite disease activity score for juvenile idiopathic arthritis

    Arthritis Care & Research · 2009 · 10.1002/art.24516

  • The pattern of response to anti–interleukin‐1 treatment distinguishes two subsets of patients with systemic‐onset juvenile idiopathic arthritis

    Arthritis & Rheumatism · 2008 · 10.1002/art.23437

  • Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial

    The Lancet · 2008 · https://doi.org/10.1016/s0140-6736(08)60998-8

  • Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis

    New England Journal of Medicine · 2008 · 10.1056/nejmoa0706290

  • A randomized, placebo‐controlled trial of infliximab plus methotrexate for the treatment of polyarticular‐course juvenile rheumatoid arthritis

    Arthritis & Rheumatism · 2007 · 10.1002/art.22838

  • Juvenile idiopathic arthritis

    The Lancet · 2007 · 10.1016/s0140-6736(07)60363-8

  • Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia

    The Journal of Experimental Medicine · 2005 · 10.1084/jem.20050085

  • Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

    The Journal of Pediatrics · 2005 · 10.1016/j.jpeds.2004.12.016

  • A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate

    Arthritis & Rheumatism · 2004 · 10.1002/art.20288

  • Preliminary definition of improvement in juvenile arthritis

    Arthritis & Rheumatism · 1997 · 10.1002/1529-0131(199707)40:7<1202::aid-art3>3.0.co;2-r

  • Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation.

    Journal of Clinical Investigation · 1997 · 10.1172/jci119207

Current projects

    No projects listed.